100 related articles for article (PubMed ID: 6819645)
1. Enhanced affinity for arachidonic acid in platelet-rich plasma from rats with Adriamycin-induced nephrotic syndrome.
Delaini F; Poggi A; Donati MB
Thromb Haemost; 1982 Dec; 48(3):260-2. PubMed ID: 6819645
[TBL] [Abstract][Full Text] [Related]
2. Platelet survival and function in rats with enhanced thrombotic tendency.
Delaini F; Dejana E; Reyers I; Vicenzi E; De Bellis Vitti G; Poggi A; Donati MB
Thromb Haemost; 1985 Dec; 54(4):739-43. PubMed ID: 3937273
[TBL] [Abstract][Full Text] [Related]
3. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
4. The metabolism of arachidonic acid by platelets in nephrotic syndrome.
Schieppati A; Dodesini P; Benigni A; Massazza M; Mecca G; Remuzzi G; Livio M; de Gaetano G; Rossi EC
Kidney Int; 1984 Apr; 25(4):671-6. PubMed ID: 6434788
[TBL] [Abstract][Full Text] [Related]
5. Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration.
Bennett A; Cameron JS
Clin Nephrol; 1987 Apr; 27(4):182-8. PubMed ID: 3107859
[TBL] [Abstract][Full Text] [Related]
6. Malondialdehyde formation in rat platelet-rich plasma. I.A kinetic approach.
Rajtar G; Livio M; Merino J; de Gaetano G
Thromb Haemost; 1980 Oct; 44(2):49-51. PubMed ID: 7455990
[TBL] [Abstract][Full Text] [Related]
7. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
Block HU; Förster W; Heinroth I
Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
[TBL] [Abstract][Full Text] [Related]
8. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H
Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650
[TBL] [Abstract][Full Text] [Related]
9. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
Ostermann G; Block HU; Till U
Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
[TBL] [Abstract][Full Text] [Related]
10. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W
Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
[TBL] [Abstract][Full Text] [Related]
12. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
[TBL] [Abstract][Full Text] [Related]
13. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472
[TBL] [Abstract][Full Text] [Related]
14. Aggregation and inhibition of rat platelets, and the formation of endoperoxide metabolites.
Hwang DH
Prostaglandins Med; 1980 Sep; 5(3):163-73. PubMed ID: 7413850
[TBL] [Abstract][Full Text] [Related]
15. Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill.
Sadurska B; Tacconi MT; di Minno G; Roncaglioni MC; Pangrazzi J; Donati MB; Bizzi A; Silver MJ
Thromb Haemost; 1981 Apr; 45(2):150-3. PubMed ID: 7256698
[TBL] [Abstract][Full Text] [Related]
16. Sex difference in the effect of aspirin on rat platelet aggregation and arachidonic acid metabolism.
Morikawa M; Kojima T; Inoue M; Tsuboi M
Jpn J Pharmacol; 1985 Apr; 37(4):317-23. PubMed ID: 3925205
[TBL] [Abstract][Full Text] [Related]
17. Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis.
Ulu N; Buikema H; van Gilst WH; Navis G
Nephrol Dial Transplant; 2008 Jun; 23(6):1854-60. PubMed ID: 18218687
[TBL] [Abstract][Full Text] [Related]
18. Malondialdehyde formation in rat platelet-rich plasma. II. Modification of the reaction kinetics by aspirin and indomethacin in vitro.
Livio M; Rajtar G; Merino J; de Gaetano G
Thromb Haemost; 1980 Oct; 44(2):52-5. PubMed ID: 7455991
[TBL] [Abstract][Full Text] [Related]
19. [Endoperoxide prostaglandin synthetase from the microsomal fraction of human platelets].
Mevkh AT; Basevich VV; Varfolomeev SD
Biokhimiia; 1982 Oct; 47(10):1635-40. PubMed ID: 6816299
[TBL] [Abstract][Full Text] [Related]
20. Blood platelet behaviour in mothers and neonates.
Andrews NP; Broughton Pipkin F; Heptinstall S
Thromb Haemost; 1985 Jun; 53(3):428-32. PubMed ID: 3931289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
